CAELYX ® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER
Condition: Breast Cancer Intervention: Drug: Caelyx® Sponsors: European Institute of Oncology; Janssen-Cilag International NV Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials